Scarica l'app Stockscreener
18.46
14.59%
2.35
Dopo l'orario di chiusura:
19.32
0.86
+4.66%
Precedente Chiudi:
$16.11
Aprire:
$15.39
Volume 24 ore:
268.18K
Relative Volume:
5.23
Capitalizzazione di mercato:
$58.68M
Reddito:
-
Utile/perdita netta:
$-68.80M
Rapporto P/E:
-15.78
EPS:
-1.17
Flusso di cassa netto:
$-59.06M
1 W Prestazione:
+72.52%
1M Prestazione:
+100.43%
6M Prestazione:
+3,903%
1 anno Prestazione:
+2,316%
Intervallo 1D:
$15.39
$19.22
Intervallo di 1 settimana:
$10.45
$19.22
Portata 52W:
$0.257
$19.22
Passage Bio Inc Stock (PASG) Company Profile
Nome
Passage Bio Inc
Settore
Industria
Telefono
(267) 866-0312
Indirizzo
ONE COMMERCE SQUARE, PHILADELPHIA, PA
Confronta PASG con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PASG
Passage Bio Inc
|
18.46 | 51.21M | 0 | -68.80M | -59.06M | -1.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Passage Bio Inc Stock (PASG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-29 | Ripresa | Wedbush | Outperform |
| 2024-09-03 | Iniziato | Rodman & Renshaw | Buy |
| 2022-03-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-01-19 | Downgrade | Goldman | Buy → Neutral |
| 2021-07-01 | Iniziato | Raymond James | Outperform |
| 2021-06-15 | Iniziato | BTIG Research | Buy |
| 2021-03-04 | Aggiornamento | Goldman | Neutral → Buy |
| 2021-02-04 | Iniziato | Guggenheim | Buy |
| 2021-01-25 | Iniziato | Wedbush | Outperform |
| 2021-01-04 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-12-11 | Iniziato | Citigroup | Neutral |
| 2020-08-14 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-06-25 | Downgrade | Goldman | Buy → Neutral |
| 2020-03-25 | Iniziato | Chardan Capital Markets | Buy |
| 2020-03-24 | Iniziato | Cowen | Outperform |
| 2020-03-24 | Iniziato | Goldman | Buy |
| 2020-03-24 | Iniziato | JP Morgan | Overweight |
Mostra tutto
Passage Bio Inc Borsa (PASG) Ultime notizie
Aug Highlights: Is Ares Management Corporation stock attractive after correction2025 Retail Activity & Stock Portfolio Risk Management - moha.gov.vn
Passage Bio Reports Promising Data in Trial for Frontotemporal Dementia Treatment - MSN
Quicktouch Technologies Limited Bounces Off Moving Average SupportDividend Stock Watch & Small Investment Big Gains - earlytimes.in
Earnings Chart Overlay Points to Rajesh Power Services Limited UpsideStock Price Divergence & Free Dynamic Capital Growth - bollywoodhelpline.com
Trendlines Converge — Decision Point for Affle (India) LimitedPrice Action Analysis & Free Turn Volatility To Profit - bollywoodhelpline.com
Is Maxposure Limited in Accumulation Phase NowSector ETF Performance & High Return Stock Ideas - bollywoodhelpline.com
Live Scanner Shows Breakout on Paras Defence and Space Technologies LimitedEarnings Volatility Patterns & Big Gains Low Budget - bollywoodhelpline.com
Spright Agro Limited (531205) Gets Regulatory ApprovalCandlestick Pattern Analysis & Set Up Real-Time Alerts – It’s Free - bollywoodhelpline.com
Chartists Watching For Breakout in Nakoda Group of Industries LimitedInstitutional Buying Trends & Consistent High Yield Stocks - bollywoodhelpline.com
Passage Bio Stock: Niche Gene Therapy Player Tests Investor Patience As Wall Street Turns Cautiously - AD HOC NEWS
Passage Bio (PASG) Stock Analysis Report | Financials & Insights - Benzinga
Derivatives Limited Experts SayTrading Volume Trends & Discover Your Financial Freedom Formula - bollywoodhelpline.com
Tara Chand Logistic Solutions Limited Matches Institutional Buying FilterMean Reversion Trades & Fast Profit Trading Tips - bollywoodhelpline.com
Passage Bio Approves 1-for-20 Reverse Stock Split to Maintain Nasdaq Compliance - MSN
Passage Bio Inc Stock Analysis and ForecastMarket Volatility Update & High Profit Investment Ideas - earlytimes.in
KeerthiKumar s Stock PortfolioHigh Beta Stocks & Build Wealth With Strategy - bollywoodhelpline.com
Is Rajasthan Tube Manufacturing Company Limited Starting a New UptrendVolume Profile Analysis & Small Budget Big Profits - bollywoodhelpline.com
Gini Silk Mills Limited Attempts Reversal From Key SupportProtective Put Strategies & Free High Yield Portfolio Picks - bollywoodhelpline.com
Why Passage Bio Inc. stock is rated strong buy2025 Market Overview & Verified Momentum Stock Alerts - Улправда
Why Passage Bio Inc. stock is seen as undervaluedQuarterly Trade Report & Community Verified Watchlist Alerts - Улправда
Will Passage Bio Inc. stock sustain high P E ratiosJuly 2025 Short Interest & High Return Trade Guides - Улправда
Will Passage Bio Inc. stock benefit from green energy trendsJuly 2025 Review & Stepwise Trade Signal Guides - DonanımHaber
Will Passage Bio Inc. stock benefit from sector rotation2025 AllTime Highs & Safe Entry Trade Signal Reports - Улправда
What analyst consensus says on Passage Bio Inc. stockJuly 2025 Outlook & AI Forecasted Stock Moves - Улправда
Passage Bio Earnings Notes - Trefis
Affle (India) Limited Flashes Buy Signal on Multi Timeframe ChartEquity Performance Review & Low Risk Investment Tips - bollywoodhelpline.com
Aug PreEarnings: Is Passage Bio Inc stock a buy on dips2025 Price Momentum & Technical Confirmation Trade Alerts - moha.gov.vn
Financial Comparison: Passage Bio (NASDAQ:PASG) versus PepGen (NASDAQ:PEPG) - Defense World
Passage Bio (PASG) Price Target Increased by 21.85% to 40.39 - Nasdaq
What drives Passage Bio Inc stock priceGrowth Stock Opportunities & Affordable Investment Portfolio - earlytimes.in
How Passage Bio Inc. stock compares to industry benchmarksPortfolio Risk Report & Free Fast Gain Swing Trade Alerts - Newser
Is Passage Bio Inc. stock a safe haven assetMarket Growth Report & Pattern Based Trade Signal System - Newser
Why Passage Bio Inc. stock is a must watch in 2025Market Rally & Free Community Supported Trade Ideas - Newser
Passage Bio to Present at Two Major Investor Conferences - MSN
Gains Recap: Why Passage Bio Inc. stock is seen as undervalued2025 Momentum Check & Free High Accuracy Swing Entry Alerts - moha.gov.vn
How currency fluctuations impact Passage Bio Inc. stockMarket Risk Analysis & Verified Stock Trade Ideas - moha.gov.vn
Risk Off: Will Passage Bio Inc. stock sustain high P E ratiosQuarterly Portfolio Report & Free Technical Confirmation Trade Alerts - moha.gov.vn
Brokerages Set Passage Bio, Inc. (NASDAQ:PASG) Target Price at $42.67 - Defense World
Ocugen CEO to Spotlight Gene Therapy Breakthroughs at High-Profile Growth Conference - MyChesCo
Passage Bio (PASG) Price Target Decreased by 45.15% to 33.15 - MSN
Lucid Capital Markets initiates Passage Bio stock with Buy rating By Investing.com - Investing.com Canada
Lucid Capital Markets initiates Passage Bio stock with Buy rating - Investing.com India
Passage Bio, Inc. (PASG) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
How Passage Bio Inc. stock compares to market leadersInsider Selling & AI Powered Market Trend Analysis - newser.com
Is Passage Bio Inc. stock bottoming out2025 Volatility Report & Proven Capital Preservation Tips - newser.com
Passage Bio Pushes Toward Key 2026 Milestones as Gene Therapy Program Accelerates - MSN
How Passage Bio Inc. stock reacts to Fed rate cuts2025 Momentum Check & Low Risk High Win Rate Picks - newser.com
Applying chart zones and confluence areas to Passage Bio Inc.2025 Bull vs Bear & Safe Swing Trade Setups - newser.com
Passage Bio Inc Azioni (PASG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.52%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):